- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04461132
The Effect of Manual Lymphatic Drainage
July 2, 2020 updated by: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Investigation of the Effect of Manual Lymphatic Drainag on Venous Ulcer Healing Rate
In venous ulcer, venous insufficiency is accompanied by lymphatic insufficiency.
Manual lymphatic drainage (mld) technique cause to increase contraction rate of lymphatic collector and venous flow.
It is known that Manual lymphatic drainage accelerates microcirculation, enabling nutrients and oxygen to reach tissues and at the same time removing residual substances from the tissue.
We hypothesis that if we inrease to lypmhatic activity with MLD, we could stimulate healing of ulcer.
The aim of this study to investigate the effect of manual lymphatic drainage on venous ulcer healing.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- İstanbul Sağlık Bilimleri University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- with venous ulcer unhealing for at least 6 weeks
- Without enfection
- vascular surgery is not indicated
- There is no obstruction to apply MLD and compression to lower extremty
Exclusion Criteria:
- with diabetic mellutus
- with enfection
- with ABI<0,7
- Patients who have undergone venous vascular surgery
- Patients undergoing active wound closure treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Manual Lymphatic Drainage Group
All patients were treated 3 times a week for 4 weeks.
The treatment program of these patients included manual lymphatic drainage on the leg, skin care, bandaging and exercise.
|
MLD vith vodder technique was applied to leg
Wound was cleaned with salin and covered by dressing without including active products
breathing and foot pump exercise was prescribed
|
|
SHAM_COMPARATOR: Shame Manual Lymphatic Drainage Group
All patients were treated 3 times a week for 4 weeks.
The treatment program of these patients included shame manual lymphatic drainage on the leg, skin care, bandaging and exercise.
Shame manual lymphatic drainage include light touches instead of real manual lymphatic drainage techniques
|
Wound was cleaned with salin and covered by dressing without including active products
breathing and foot pump exercise was prescribed
manual lymphatic drainage was applied with light touch instead of real mld techniques
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of wound healing
Time Frame: Change from baseline wound healing following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
Wound was assesed by analyzing photographes of wound with Tracker software.
|
Change from baseline wound healing following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
|
Evaluation of range of motion of ankle
Time Frame: Change from baseline range of motion following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
range of motion of ankle was measured with goniometer
|
Change from baseline range of motion following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
|
Evaluation of pain
Time Frame: Change from baseline pain following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
Pain was evaluated by Visual Analog Scale between 0 (no pain)-10 (extreme) pain.
|
Change from baseline pain following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
|
evaluation of edema
Time Frame: Change from baseline edema following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
edema was measured by 3D scanner
|
Change from baseline edema following the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
|
evaluation of quality of life
Time Frame: Change from baseline quality of life following scores the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
quality of life was evaluated by SF- 12
|
Change from baseline quality of life following scores the end of treatment (12. treatment session) and 1 month after the end of treatment.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: Nilüfer Kablan, PhD, University of Health Science
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Azoubel R, Torres Gde V, da Silva LW, Gomes FV, dos Reis LA. [Effects of the decongestive physiotherapy in the healing of venous ulcers]. Rev Esc Enferm USP. 2010 Dec;44(4):1085-92. doi: 10.1590/s0080-62342010000400033. Portuguese.
- Crawford JM, Lal BK, Duran WN, Pappas PJ. Pathophysiology of venous ulceration. J Vasc Surg Venous Lymphat Disord. 2017 Jul;5(4):596-605. doi: 10.1016/j.jvsv.2017.03.015.
- de Roos KP, Wittens CH, Maessen-Visch MB, van der Wegen-Franken CP. [Universal Dutch guideline on 'Venous disease']. Ned Tijdschr Geneeskd. 2014;158(0):A8076. Dutch.
- Williams A. Manual lymphatic drainage: exploring the history and evidence base. Br J Community Nurs. 2010 Apr;15(4):S18-24. doi: 10.12968/bjcn.2010.15.Sup3.47365.
- Kelechi TJ, Johnson JJ, Yates S. Chronic venous disease and venous leg ulcers: An evidence-based update. J Vasc Nurs. 2015 Jun;33(2):36-46. doi: 10.1016/j.jvn.2015.01.003.
- Hampton S. An introduction to various types of leg ulcers and their management. Br J Nurs. 2006 Jun 8-21;15(11):S9-13. doi: 10.12968/bjon.2006.15.Sup2.21235.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 11, 2018
Primary Completion (ACTUAL)
July 3, 2019
Study Completion (ACTUAL)
May 29, 2020
Study Registration Dates
First Submitted
July 2, 2020
First Submitted That Met QC Criteria
July 2, 2020
First Posted (ACTUAL)
July 8, 2020
Study Record Updates
Last Update Posted (ACTUAL)
July 8, 2020
Last Update Submitted That Met QC Criteria
July 2, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.2017.209
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venous Insufficiency
-
Value Outcomes Ltd.Alfasigma S.p.A.RecruitingChronic Venous Disease | Chronic Insufficiency VenousCzechia
-
Necmettin Erbakan UniversityActive, not recruitingChronic Venous Insufficiency C2 and BelowTurkey (Türkiye)
-
State Budgetary Healthcare Institution, National...CompletedEndothelial Dysfunction | Venous Insufficiency of Leg | Venous Insufficiency (Chronic)(Peripheral)Russian Federation
-
Universidade do PortoCompletedDrainage | Venous Insufficiency of Leg | Chronic Venous DiseasePortugal
-
GCS Ramsay Santé pour l'Enseignement et la RechercheVivactis M2ResearchRecruitingSuperficial Venous InsufficiencyFrance
-
C. R. BardActive, not recruiting
-
Istanbul Arel UniversityBahçeşehir UniversityEnrolling by invitationChronic Venous Insufficiency, Pelvic Floor, ExerciseTurkey (Türkiye)
-
Medtronic EndovascularCompletedVenous Insufficiency of LegUnited Kingdom, Denmark, Germany, Netherlands
-
Fundação Educacional Serra dos ÓrgãosCompletedChronic Venous InsufficiencyBrazil
-
TheraclionCompletedChronic Venous InsufficiencyUnited States, Austria, Czechia
Clinical Trials on Manual Lymphatic drainage (MLD)
-
Istanbul Medeniyet UniversityCompleted
-
Anne Arundel Health System Research InstituteTerminated
-
Haute Ecole de Santé VaudUniversity of Lausanne Hospitals; University of Applied Sciences of Western...CompletedKnee Arthroplasty, TotalSwitzerland
-
Camilo Jose Cela UniversityNot yet recruiting
-
Vanderbilt UniversityCompleted
-
The University of Texas Health Science Center,...HeadStrong FoundationTerminated
-
Marmara UniversityCompletedTelerehabilitation | Breast Cancer Related LymphedemaTurkey
-
Tactile MedicalVanderbilt University Medical CenterCompletedLymphedema | Lymphedema, Secondary | Lymphedema; Surgical | Lymphedema of Face | Lymphedema Due to RadiationUnited States
-
University of California, San FranciscoFoundation for Physical Therapy, Inc.CompletedLymphedema of Upper Limb | Lymphedema, SecondaryUnited States
-
Camilo Jose Cela UniversityCompleted